An Evolving Role for DEPTOR in Tumor Development and Progression
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Deregulation of the mammalian target of rapamycin (mTOR) signaling pathway has been found in a variety of human cancers. However, the exact molecular mechanism how the mTOR signaling pathway is regulated remains largely elusive. Recently, DEPTOR was identified as an endogenous mTOR inhibitor that could suppress mTOR activity in vivo. More importantly, accumulated evidence has implicated that DEPTOR plays a pivotal role in the development and progression of human malignances, which could in part be mediated through its inhibitory role toward mTOR. Furthermore, three independent laboratories including our own have demonstrated that the stability of DEPTOR is controlled by the SCF(β-TrCP) E3 ubiquitin ligase and deregulated DEPTOR destruction might contribute to hyperactivation of mTOR in pathologic conditions including cancer. This review discusses the recent literature regarding the function of DEPTOR involved in cell growth, apoptosis, autophagy, epithelial-mesenchymal transition, and drug resistance, all of which are associated with the pathogenesis of human cancers. Moreover, we also summarize that targeting DEPTOR may be a novel strategy for achieving better anticancer treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Insulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059 · cited 1×
“[7] Pollak M (2008).”
Mathew, R., Karantza-Wadsworth, V., & White, E. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2254 · Cited by 1,798 · cited 4×
“Autophagy is a tightly regulated process that allows the cells to maintain a balance between the synthesis, degradation, and subsequent recycling of intracellular constituents [55].”
BackgroundInfluentialRAS oncogenes: weaving a tumorigenic web
Pylayeva-Gupta, Y., Grabocka, E., & Bar-Sagi, D. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3106 · Cited by 1,789 · cited 1×
“[13] Pylayeva-Gupta Y, Grabocka E, and Bar-Sagi D (2011).”
Wnt signalling and its impact on development and cancer
Klaus, A., & Birchmeier, W. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2389 · Cited by 1,595 · cited 1×
“[8] Klaus A and Birchmeier W (2008).”
mTOR and cancer: insights into a complex relationship
Sabatini, D. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1974 · Cited by 1,322
Peterson, T. R., Laplante, M., Thoreen, C. C., Sancak, Y., Kang, S. A., Kuehl, W. M., Gray, N. S., & Sabatini, D. M. (2009) · Cell · doi:10.1016/j.cell.2009.03.046 · Cited by 1,202 · cited 10×
“For example, DEPTOR is overexpressed in multiple myeloma cells, and this overexpression is necessary for Akt activation and cell survival [16].”
BackgroundInfluentialHypoxia signalling through mTOR and the unfolded protein response in cancer
Wouters, B. G., & Koritzinsky, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2501 · Cited by 894 · cited 2×
“Both biochemical and genetic studies have established that mTOR is an important sensor of various metabolic and nutrient stresses, receiving and interpreting environmental inputs and transducing them to the downstream signaling pathways to control cellular metabolism, cellular growth, and survival [21].”
BackgroundDegradation of Cdc25A by β-TrCP during S phase and in response to DNA damage
Busino, L., Donzelli, M., Chiesa, M., Guardavaccaro, D., Ganoth, D., Valerio Dorrello, N., Hershko, A., Pagano, M., & Draetta, G. F. (2003) · Nature · doi:10.1038/nature02082 · Cited by 447 · cited 3×
“Recent studies have identified multiple specific substrates of β-TrCP including Cdc25a [25,26], β-catenin [27,28], caspase 3 [29], Emi1 [30,31], Mdm2 [32], IκB [33], PDCD4 (programmed cell death 4) [34], Snail [35], Claspin [36], REST (RE1-silencing transcription factor) [37,38], BimEL (Bcl-2 interacting mediator of c…”
BackgroundPhosphoinositide signalling in cancer: beyond PI3K and PTEN
Bunney, T. D., & Katan, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2842 · Cited by 400 · cited 1×
“[5] Bunney TD and Katan M (2010).”
SCFβ-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase
Jin, J., Shirogane, T., Xu, L., Nalepa, G., Qin, J., Elledge, S. J., & Harper, J. W. (2003) · Genes & Development · doi:10.1101/gad.1157503 · Cited by 340
Cited by
Rapamycin and mTOR: a serendipitous discovery and implications for breast cancer
Seto, B. (2012) · Clinical and Translational Medicine · doi:10.1186/2001-1326-1-29 · Cited by 149
Abnormal protein turnover and anabolic resistance to exercise in sarcopenic obesity
Nilsson, M. I., Dobson, J. P., Greene, N. P., Wiggs, M. P., Shimkus, K. L., Wudeck, E. V., Davis, A. R., Laureano, M. L., & Fluckey, J. D. (2013) · The FASEB Journal · doi:10.1096/fj.12-224006 · Cited by 87
HMGB1 knockdown increases MM cell vulnerability by regulating autophagy and DNA damage repair
Guo, X., He, D., Zhang, E., Chen, J., Chen, Q., Li, Y., Yang, L., Yang, Y., Zhao, Y., Wang, G., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0883-3 · Cited by 36
Metadata
- Authors
- Wang, Z., Zhong, J., Inuzuka, H., Gao, D., Shaik, S., Sarkar, F. H., & Wei, W.
- Venue
- Neoplasia
- Publisher
- Elsevier BV
- Published
- 2012-05
- Volume
- 14
- Issue
- 5
- Pages
- 368-375
- ISSN
- 1476-5586 (ISSN-L)
- OpenAlex
- W1605833010
- Cited by
- 65
- References
- 12
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An Evolving Role for DEPTOR in Tumor Development and Progression. https://app.cochat.ai/papers/10.1593/neo.12542
- The paper
- Wang, Z., Zhong, J., Inuzuka, H., Gao, D., Shaik, S., Sarkar, F. H., & Wei, W. (2012). An Evolving Role for DEPTOR in Tumor Development and Progression. Neoplasia. https://doi.org/10.1593/neo.12542
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.